Trial Profile
A study of ramucirumab in Japanese patients with advanced gastric cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Feb 2018
Price :
$35
*
At a glance
- Drugs Ramucirumab (Primary) ; Paclitaxel
- Indications Gastric cancer
- Focus Therapeutic Use
- 22 Feb 2018 New trial record
- 20 Jan 2018 Results of final analysis presented at the 2018 Gastrointestinal Cancers Symposium